Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-31

FDA Approved: EYE ALLERGY RELIEF — Supplemental Application (DOLGENCORP, LLC)

View source ↗

Summary

FDA approved a supplemental application for Eye Allergy Relief containing pheniramine maleate and naphaZoline hydrochloride, manufactured by DolGenCorp, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE)

Snippet

SUPPL AP for EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE)